Ipsen Central Contact
Slough, Berkshire, SL1 3XE, United Kingdom
NCT Number: NCT00455884
This study is a multicenter, open-label, observational, post marketing surveillance program to collect information on the use of NutropinAq® in adults suffering from Growth Hormone Deficiency in Germany, Italy, and United Kingdom
Looking for future studies?
Notify MeAll sexes
Observational
Slough, Berkshire, SL1 3XE, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: when reported
Time frame: when reported
Time frame: when reported
Time frame: when reported
Ipsen
Industry
International Cooperative Metabolic Study (iNCMS) of NutropinAq® [Somatropin (rDNA Origin) Injection] Replacement Therapy in Adults With Growth Hormone Deficiency
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00455728
Growth Hormone Disorders
Slough, Berkshire, United Kingdom
View Trial Details